Clinical Trials Browser

Phase 4 × OTHER × relatlimab × Clear all

NCT07504796 2026-04-01

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

Phase 4 Not yet recruiting

Melanoma